Etai Kramer

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can’t wait. That’s why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we’ve shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.

Poalim Equity (FKA Poalim Capital Markets) is Bank Hapoalim’s investment platform. We invest across various sectors, geographies and strategies alongside a wide range of advisory services addressing our clients’ financial needs. As a merchant bank, we offer advisory services addressing our clients’ financial needs, while providing comprehensive solutions throughout the entire life-cycle of the company.

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can’t wait. That’s why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we’ve shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.

OurCrowd is a global venture and alternatives investment platform that empowers institutions and individuals to invest and engage in emerging companies, funds and other private market alternative assets. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. OurCrowd portfolio companies have achieved more than 50 exits. It has received more than $1.9B in committed funds for its 300+ portfolio companies and venture funds. Visit us at: www.ourcrowd.com

Arnon, Tadmor-Levy is a preeminent Israeli law firm. With approximately 450 lawyers and interns, including 140 partners, the law firm of Arnon, Tadmor-Levy is a leader in its areas of practice. The firm offers diverse legal services and a proven track record of success to its clients, which include many of Israel’s largest companies, government and public entities, premier investment funds, and leading multinational corporations. The firm integrates top-tier expertise, creativity and an unmatched level of service, with fairness, collegial conduct and uncompromising professional conduct. The firm’s practices, as well as many of its partners and lawyers, rank highly on international and Israeli legal directories, including Chambers and Partners, The Legal 500, GCR, IFLR1000, Duns100 and BDI Code. Arnon, Tadmor-Levy dominates the Israeli legal scene across many fields. Leading practices include mergers and acquisitions; hi-tech; litigation; real estate, planning and construction; banking and payment systems; competition; project finance and energy; environment; capital markets; regulatory and administrative law; direct, indirect, real estate and municipal taxation; labor and employee matters; healthcare; municipal law; insolvency proceedings and reorganization; communications and media; transportation; aviation; tender and public procurement; and commercial law.

Fried, Frank, Harris, Shriver & Jacobson LLP advises the worlds leading corporations, investment funds and financial institutions on their most critical legal needs and business opportunities. The firms 800 lawyers are based in North America, the UK and Europe.